Therapy Areas: Infectious Diseases
9 September 2019 - - US-based biopharmaceutical company Aptorum Group Ltd. (NASDAQ: APM) is developing two preclinical drug candidates which target obesity and neuroblastoma, respectively, the company...
9 September 2019 - - US-based biopharmaceutical company Aptorum Group Ltd. (NASDAQ: APM) is developing two preclinical drug candidates which target obesity and neuroblastoma, respectively, the company...
9 September 2019 - The US Food and Drug Administration (FDA) has granted Ridgeback Biotherapeutics LP, a biotechnology company, Breakthrough Therapy designation for its mAb114, an experimental Ebola t...
30 August 2019 - - US-based pharmaceutical company VenatoRx Pharmaceuticals has initiated enrollment in its Phase 3 trial of cefepime/VNRX-5133 in patients with complicated urinary tract infections (c...
23 August 2019 - - US-based Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, are a recipient of a Phase II SBIR gra...
22 August 2019 - - US-based VenatoRx Pharmaceuticals has added pharmaceutical industry veterans, Jennifer Ellis, Dr. Paul McGovern and Lauren P. Tornetta to its development team, the company said.